Stockreport

Entrada Therapeutics Announces Closing of Initial Public Offering

Entrada Therapeutics, Inc.  (TRDA) 
PDF BOSTON, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biotechnology company aiming to transform the lives of patients by establishing [Read more]